Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis

Osteoporosis is characterized by decreased bone mineral density and increased risk of fracture. Raloxifene is one of the treatments of osteoporosis. However, the responses were variable among patients. Previous studies revealed that the genetic variants are involved in the regulation of treatment ou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Markers
Main Authors: Lu, Hsing-Fang, Chou, Po-Hsin, Lin, Gan-Hong, Chou, Wan-Hsuan, Wang, Shih-Tien, Adikusuma, Wirawan, Mugiyanto, Eko, Hung, Kuo-Sheng, Chang, Wei-Chiao
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479487/
https://ncbi.nlm.nih.gov/pubmed/32934756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8855423
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados